What is the clinical efficacy of apalutamide (Ansenko) and summary of patient use feedback

Apalutamide (Apalutamide) is a new non-steroidal anti-androgen drug, mainly used to treat metastatic castration-sensitive prostate cancer (mCSPC) and non-metastatic castration-resistant prostate cancer (nmCRPC). It inhibits the growth of cancer cells by inhibiting the activity of androgen receptors and blocking the androgen signaling pathway. As the trade name of "Erleada", apalutamide has been approved in many countries and has shown significant efficacy in multiple clinical studies.

1. Analysis of clinical efficacy

In multiple key Phase III clinical trials, apalutamide combined with androgen deprivation therapy (ADT) showed significant improvement in efficacy. For example, the TITAN study showed that apalutamide combined with ADT treated mCSPC patients, significantly prolonged progression-free survival (PFS) and overall survival (OS), and reduced the incidence of castration-resistant prostate cancer. The SPARTAN study showed that in nmCRPC patients, apalutamide combined with ADT treatment significantly reduced the risk of prostate-specific antigen (PSA) progression. In addition, the PRESTO study also confirmed that apalutamide combined with ADT in the treatment of biochemically recurrent prostate cancer patients significantly prolonged metastasis-free survival (MFS) and the onset time of castration-resistant prostate cancer.

Apalutamide has also shown promising efficacy in real-world applications. A retrospective study showed that among 186 men who received apalutamide, PSA levels decreased by 50% The proportion above span> is 88.4%, and the proportion of decline above 90% is 60.5%. However, patients previously treated with other androgen receptor signaling inhibitors (ARSI) had significantly lower PSA response rates, suggesting that the efficacy of apalutamide may be compromised in these patients.

2. Feedback from patients

According to patient reviews on Drugs.com, the average rating for apalutamide is 8.0 out of 10 points, with 81% of patients reporting a positive experience. However, a small number of patients have reported side effects such as rash, fatigue and joint pain. In the patient reviews on the WebMD website, the average score of apalutamide is 3.5 (out of 5 points). Some patients said that the drug was effective for them, but some patients reported side effects, such as dizziness, nausea, and loss of libido. These feedbacks suggest that patients may experience certain side effects when using apalutamide, but overall, the drug's efficacy is recognized by most patients.

It is worth noting that some patients have experienced serious adverse reactions while using apalutamide. For example, one patient experienced a severe allergic reaction after taking apalutamide, including rash, hypotension, and confusion, ultimately resulting in hospitalization. This reminds us that when using apalutamide, the patient's health status should be closely monitored to detect and deal with possible serious adverse reactions in a timely manner.

3. Usage Suggestions and Precautions

When using apalutamide, patients should follow the doctor's instructions, take the medication on time, and have regular blood tests to monitorPSA levels and liver and kidney function. At the same time, you should pay attention to observe whether adverse reactions such as rash, dizziness, nausea, etc. occur. If the above symptoms occur, you should seek medical treatment in time. In addition, while taking apalutamide, patients should avoid concurrent use with other drugs that may affect drug metabolism, especially strong CYP3A4 inhibitors and inducers. During the treatment process, patients should maintain good living habits, a balanced diet, and moderate exercise to improve the treatment effect.

Apalutamide, as a new type of anti-androgen drug, has shown significant efficacy in the treatment of prostate cancer, especially in combination with ADT in the treatment of mCSPC and nmCRPC patients, which can significantly prolong progression-free survival and overall survival. In real-world applications, apalutamide has also shown good efficacy, although some patients may experience certain side effects. When using apalutamide, patients should follow the doctor's instructions, undergo regular examinations, pay close attention to possible side effects, and maintain good living habits to improve the treatment effect.

Reference materials:https://www.drugs.com/